Who is sponsoring SLEEP-PARTNERS?

SLEEP-PARTNERS is sponsored by University of Sao Paulo.

What condition does SLEEP-PARTNERS study?

SLEEP-PARTNERS studies Sleep Apnea Syndromes.

What drugs are being tested in SLEEP-PARTNERS?

Interventions: Continuous positive airway pressure (CPAP), Nasal strip.

What is the status of SLEEP-PARTNERS?

SLEEP-PARTNERS is currently COMPLETED.

Last reviewed 2024-06-10 · How we verify

Cardiovascular Impact, Quality e Quantity of Sleep in Bed Partners of Patients With Obstructive Sleep Apnea (SLEEP-PARTNERS)

NCT03011294 PHASE4 COMPLETED

Obstructive sleep apnea (OSA) is a common clinical condition associate with a negative impact not limited to the patients but also to the partner that sleep in the same bed. Is it reasonable to speculate that the partner suffer sleep deprivation, increased level of irritability, insomnia, fatigue, among others due to the loud snoring caused by the OSA patient. Although previous data reported impaired sleep quality in partners of patients with OSA, it is not clear in literature whether OSA promotes cardiovascular impact and if the treatment of OSA promotes some cardiovascular benefits in (the) partner beyond the improvements in the subjective and objective sleep. Thus, the main objectives of this randomized controlled study are: to evaluate the impact of three months of randomization (treatment with nasal CPAP or nasal strips) on the endothelial function, blood pressure (ambulatory blood pressure monitoring), sleep duration (wrist actigraphy for 1 week) and sleep quality (Pittsburgh Questionnaire) and the frequency of OSA in the bed partners of patients with moderate to severe OSA.

Details

Lead sponsor	University of Sao Paulo
Phase	PHASE4
Status	COMPLETED
Enrolment	60
Start date	Sat Dec 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Jun 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Sleep Apnea Syndromes

Interventions

Continuous positive airway pressure (CPAP)
Nasal strip

Countries

Brazil